About this trial
The study aims to evaluate the clinical performance (implant and prosthetic survival/ success rates) of a novel implant-supported fixed dental prosthesis design: the dual-cantilevered single implant bridge (T-Bridge) made out of monolithic zirconia bonded to a titanium base abutment (Variobase abutments)
Eligibility criteria
Qualifiers
Age ≥ 20 years
Willingness to sign an informed consent and participate in the study
Three missing adjacent teeth in the posterior site.
Tooth gap of 21-24 mm.
Disqualifiers
Any physical or mental disorder that would interfere with the ability to perform adequate oral hygiene or the capability of providing written informed consent and compliance with the protocol
Any disorder that would interfere with wound healing or represent a contraindication for implant surgery, such as but not limited to uncontrolled diabetes or conditions resulting in or requiring immunosuppression, radiation, chemotherapy, frequent use of antibiotics or antiresorptive medication such as bisphosphonates.
Pregnancy or lactation
Heavy smoking habit with ≥ 10 cig/d
Trial design
Treatments tested in this trial
- Dual-cantilevered implant bridge
- 3-unit iFDP
Treatment groups
Sponsors and collaborators
University of Bern
Lead sponsor
ITI International Team for Implantology, Switzerland
Collaborator